HROW
Harrow Health Inc
33.60$
-2.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 88.4% | 41.6% | 54.1% | 36.8% | 66.4% | 62.2% | 71.3% | 61.7% | 75.3% | 44.6% | 48.8% | 53.0% | |
| 80.2% | 19.0% | 32.5% | 16.8% | 13.4% | 8.0% | 7.1% | 42.9% | 61.3% | 23.8% | 12.1% | 18.3% | |
| 80.2% | 19.0% | 32.5% | 16.8% | 56.7% | 50.7% | 57.0% | 51.5% | 61.3% | 26.5% | 12.1% | 18.3% | |
| 0.8% | 5.9% | 10.7% | 6.8% | 4.0% | 3.4% | 4.6% | 4.6% | 4.1% | 11.7% | 30.0% | 27.8% | |
| 3.6% | 10.0% | 6.8% | 9.4% | 3.7% | 5.6% | 6.9% | 4.3% | 4.2% | 3.5% | 2.8% | 3.4% | |
| 2.4% | 18.8% | 26.8% | 26.0% | 12.9% | 9.1% | 7.7% | 3.2% | 2.2% | – | – | – | |
| 3.2% | 17.5% | 8.2% | 9.3% | 4.5% | 0.6% | 0.6% | 0.3% | 0.2% | 0.1% | 0.1% | 0.1% | |
| 6.0% | 22.2% | 10.9% | 12.0% | 6.2% | 4.0% | 4.4% | 17.4% | 16.5% | 51.3% | 48.0% | 43.9% | |
| 20.4% | 109.8% | 76.4% | 89.1% | 49.9% | 53.6% | 53.3% | 88.9% | 82.9% | 77.5% | 82.2% | 87.0% | |
| 15.2% | 38.0% | 36.4% | 24.1% | 24.1% | 20.8% | 18.8% | 9.9% | 11.9% | 15.8% | 23.5% | 24.1% | |
| 0.2% | 0.1% | 17.9% | 2.5% | 8.0% | 4.1% | 7.8% | 0.3% | 0.5% | 0.3% | 0.1% | 0.2% | |
| 7.7% | 24.1% | 13.0% | 16.2% | 10.0% | 12.5% | 6.3% | 5.3% | 11.9% | 6.9% | 10.0% | 8.9% | |
| 0.2% | 59.0% | 29.1% | 58.6% | 24.3% | 20.7% | 21.5% | 72.9% | 66.3% | 58.8% | 56.4% | 60.9% | |
| 79.6% | -9.8% | 23.6% | 10.9% | 50.1% | 46.9% | 47.3% | 11.5% | 17.1% | 22.6% | 17.9% | 13.1% | |
| -408.8% | -408.8% | -282.1% | -371.4% | -150.1% | -125.3% | -134.7% | -97.0% | -69.7% | -43.0% | -38.9% | -39.2% | |
| 89.2% | 67.8% | 46.8% | 83.7% | 48.2% | 44.8% | 45.1% | 27.2% | 17.5% | 10.5% | 9.2% | 9.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.